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Abstract
We conducted a simulation study to illustrate that P values can suggest but not confirm statistical 
significance; and they may not indicate epidemiological significance (importance). We 
recommend that researchers consider reporting effect sizes as P values in conjunction with 
confidence intervals or point estimates with standard errors to indicate precision (uncertainty).
Since 1999, experts have written about the inappropriate use of the P value to make 
judgments about the scientific significance (importance) of research findings in leading 
medical and scientific journals.1–6 The primary concern is that a P value computed in a 
statistical significance test does not contain information about the clinical significance—the 
importance of an intervention—or epidemiological importance of the finding—a measure 
for the prevention and control of a disease in a population.7,8 In 2016, the American 
Statistical Association issued a formal statement clarifying the proper use and interpretation 
of the P value and advising against using the P value to determine scientific significance of 
research findings.9 The purpose of this article is to illustrate, with a simple simulated 
example, why small P values and narrow 95% confidence intervals do not indicate the 
clinical significance or epidemiological importance of a research finding. We recommend 
that authors report and interpret P values in conjunction with effect sizes and standard errors, 
or confidence intervals to support limited statements about the precision (uncertainty) and 
statistical significance of the findings. Conclusions about the clinical significance or 
epidemiological importance of research findings require clinical or epidemiological 
judgments that do not depend on statistical evidence alone.
METHODS
We devised an example of a prevalence difference known to be epidemiologically 
insignificant or unimportant. The hypothesis is to test the prevalence difference of 2 
interventions—A and B. To compute the P value for the test, it is assumed that intervention 
A reduces the prevalence of an STD by 31% in group A and intervention B reduces the 
prevalence of the same STD by 27% in group B. Groups A and B are equal in size, and 
interventions A and B are equally effective. The relative effect of intervention A to that of 
Correspondence: Joseph Kang, PhD, Mailstop E-02, Division of STD Prevention, Centers for Disease Control and Prevention, 12 
Corporate Square Blvd, Atlanta, GA 30329. yma9@cdc.gov. 
Conflict of interest: none declared.
HHS Public Access
Author manuscript
Sex Transm Dis. Author manuscript; available in PMC 2018 January 10.
Published in final edited form as:





















intervention B is 1.21 as the prevalence odds ratio. We know from practical experience that a 
4% difference in the effects of interventions A and B is not clinically significant or 
important. Let us suppose a 20% difference would be clinically important. Although 20% 
may be arbitrary, is comparable to the gender gap in 2014 gonorrhea rates—120.1 cases per 
105 among men and 101.3 cases per 105 among women.10 An intervention that closes that 
gap, that is, reduces the difference by 18.8%, would be epidemiologically important because 
closing the gap is a national goal. For our statistical simulation, the R statistical program11 
was used and is available as the supplementary document.
RESULTS
Using the outcomes described above, data can be readily simulated with different sample 
sizes. Figure 1 illustrates that as the sample size (N) and power increase, the P value 
becomes smaller, even when there is no change in the absolute difference of 4% (measure of 
effect). All the data points of this figure were generated with the same prevalence odds ratio 
of 1.21 and the absolute difference of 4%, as described in the previous section. For example, 
with a total sample size N of 100, P = 0.24 and appears not to be “statistically significant" 
using the standard threshold of P < 0.05. In contrast, a sample size N of 1800 results in P = 
0.002, a value universally considered “statistically significant.” This phenomenon occurs 
because the P value is directly influenced by the sample size. As sample size increases, P 
values become smaller, crossing the 0.05 threshold to become “significant” regardless of 
whether the outcome is clinically significant. Without context, reporting only a P value for 
the group difference as evidence of its clinical significance or epidemiological importance 
will often result in misinterpretation. As stated above, the absolute difference in prevalence 
between the two groups in our example is 4%, a difference that is known to be unimportant. 
Thus, its effect size—the estimated difference of the prevalence rates (4%)—should be 
reported as well.
As shown in Figure 1, some small P values will show statistically significant differences. 
Instead of directly associating small P values and statistical significance with clinical 
significance, small P values should be interpreted as evidence supporting a rejection of the 
assumptions that the particular set of data are consistent with the proposed model for the 
data.9 P values in Figure 1 were modeled under a null hypothesis assuming a prevalence 
ratio of 1.0. P values less than 0.05 mean the data are incompatible with the model’s null 
hypothesis assuming a prevalence ratio of 1.0, which should be rejected.9 In the example 
provided, this is the only information the P value can provide. The incompatibility of the 
data and the statistical model’s null hypothesis indicated by P values less than 0.05 provides 
justification for a preliminary, not definitive or final, rejection of the null hypothesis.
Figure 2 shows that as the sample size N increases, the confidence interval for the effect size 
becomes narrower. With N =1800, confidence intervals for the estimated prevalence rates are 
reported as 31% to 37% and 24% to 30%, respectively. Equivalently, an estimated 
prevalence ratio of 1.38 can be reported with its confidence interval of 1.13 to 1.69 or its 
standard error of ±0.13. Neither statement about precision, however, justifies any statement 
about clinical significance or epidemiological importance.
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In this article, we illustrated that P values measure statistical significance, but not necessarily 
clinical significance or epidemiological importance. The evaluation of public health 
interventions requires more careful epidemiological investigations including the assessment 
of the magnitude of attributable risks than simply reporting P values. When the P value was 
first proposed by Ron Fisher as an index of statistical significance, it was never meant to be 
used as an index of clinical significance or epidemiological importance.12 The threshold of 
0.05 was intended to serve as an initial or preliminary indicator of potential statistical 
significance, neither final nor confirmatory. Some disciplines, such as genomics,13 have used 
P values to support some important discoveries, but the nature of the analysis in this respect 
is exploratory, rather than confirmatory. Even when the P value is meant to be exploratory, 
the use of 0.05 as a threshold may be misleading. Observe the horizontal dotted line at a 
significance level of 0.05 in Figure 1. If the dotted line was drawn at a significance level of 
0.1, a larger number of simulated experiments would have statistically significant P values. 
Regardless of statistical significance levels, however, the prevalence difference (4%) or 
prevalence ratio (1.21) remains clinically insignificant and epidemiologically unimportant.
As shown in the simple example presented in this article, evidence of statistical significance 
is not evidence of clinical or epidemiological importance. Smaller P values are not 
necessarily associated with larger or more important effects, and larger P values are not 
necessarily associated with clinical insignificance or epidemiological importance of the 
effect. Recall that our example had a prevalence difference of 4%, but P values in Figure 1 
varied. Thus, any analysis with a large sample size or high precision may produce a small P 
value, whereas analyses with small sample sizes or imprecise measurements may produce 
large P values even though the clinical or epidemiological effect may be important.
According to the ASA, “Cherry-picking effect sizes with small P values, also known by such 
terms as data dredging, significance chasing, significance questing, selective inference and 
“P hacking,” leads to spurious significant results.”9 One way to prevent spurious findings is 
to report both effect sizes and corresponding confidence intervals so that readers can decide 
for themselves if the difference (or ratio) in effect is big enough to be meaningful or 
important on the basis of clinical or epidemiological criteria of significance. In some cases, 
however, effect sizes are not applicable to the result of the statistical test—e.g., a goodness 
of fit test only yields a P value. Therefore, there is still utility in using a P value to make 
decisions about a model and it should not be blindly abandoned.
Scientific writing tends to convey P values as statements about the truth of a null hypothesis, 
or about the probability that random chance produced the observed data. Yet, as shown in 
our study, whether P values are statistically rejected or not, the assumed clinical 
insignificance does not change. Evaluating the clinical significance of a finding is quite 
different from assessing the statistical significance.
Generally, P values can support exploratory or preliminary judgments about statistical 
significance, but they are neither certain, nor confirmatory, nor final. Without additional 
information, such as the effect size, a confidence interval, or standard error for context, 
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readers of scientific reports do not have sufficient information in the P value alone to make 
judgments about clinical significance or epidemiological importance of the statistical 
finding, as clearly illustrated in our example. Recent increases in big data analytics in health 
science provide substantially large data sets that can produce small P values that may not be 
epidemiologically useful. Indeed, the influx of modern-day big data in population health for 
different epidemiological disciplines would require more than the P value to assess the 
importance of new discoveries. To make study findings easier to interpret and to enable 
readers to make judgments about their usefulness, we recommend that in conjunction with P 
values, researchers also report confidence intervals or effect sizes with standard errors.
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P value and power versus sample size simulation with the same absolute difference of 4%.
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Confidence interval for odds ratio (OR) versus sample size with the same absolute difference 
of 4%.
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